Demonstration of a heterogeneous transcription pattern of thyroglobulin mRNA in human thyroid tissues.
Previous reports on human thyroglobulin (hTg) modifications in thyroid carcinomas prompted us to study hTg mRNA in thyroid adenomas and carcinomas. The quantification of hTg mRNA showed a decrease in its levels of expression in both pathological conditions which differed by a factor of 2 between adenomas and carcinomas. Furthermore, PCR was used to analyse the characteristics of hTg mRNA by amplifying 4 regions of the hTg mRNA. When applied to 2 normal, 17 benign and 13 malignant pathological tissue specimens, PCR showed no modification in the size of Tg mRNA. However, abnormal sized cDNAs appeared in all tissues with no distinction between the pathologies; the Restriction Fragment Length Polymorphism study of these cDNAs suggests the existence of alternate splicing patterns in thyroglobulin mRNAs.
Bertaux
F
F
INSERM U66, Institut Gustave Roussy, Villejuif, France.
Noel
M
M
Malthiéry
Y
Y
Fragu
P
P
D000236:Adenoma / Q000235:genetics; D015139:Blotting, Southern; D002277:Carcinoma / Q000235:genetics; D002872:Chromosome Deletion; D006801:Humans; D009693:Nucleic Acid Hybridization; D015345:Oligonucleotide Probes; D016133:Polymerase Chain Reaction; D012326:RNA Splicing; D012333:RNA, Messenger / Q000235:genetics* / Q000302:isolation & purification; D015183:Restriction Mapping; D013954:Thyroglobulin / Q000235:genetics*; D013961:Thyroid Gland / Q000502:physiology* / Q000503:physiopathology; D013964:Thyroid Neoplasms / Q000235:genetics; D014158:Transcription, Genetic
D015345:Oligonucleotide Probes; D012333:RNA, Messenger; D013954:Thyroglobulin